Phenobarbital use and neurological problems in FMR1 premutation carriers.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Neurotoxicology

• Publication date

  2016-03-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.neuro.2016.01.008PMID 26802682PMCID PMC4808401
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fragile X syndrome

  2017cited by this paper
• Pesticide poisoning and neurobehavioral function among farm workers in Jiangsu, People's Republic of China.

  2016cited by this paper
• Repeated exposure to chlorpyrifos leads to prolonged impairments of axonal transport in the living rodent brain.

  2015cited by this paper
• Anxiety disorders in fragile X premutation carriers: Preliminary characterization of probands and non-probands.

  2015cited by this paper
• Putative adverse outcome pathways relevant to neurotoxicity

  2015cited by this paper
• Fragile X-Associated Tremor/Ataxia Syndrome in a Man in His 30s.

  2015cited by this paper
• Methadone use in a male with the FMRI premutation and FXTAS

  2015cited by this paper
• Addictive substances may induce a rapid neurological deterioration in fragile X-associated tremor ataxia syndrome: A report of two cases.

  2014cited by this paper
• Necessary, but not sufficient: insights into the mechanisms of mGluR mediated long-term depression from a rat model of early life seizures.

  2014cited by this paper
• Medication side effects among people with epilepsy taking phenobarbital in Zambia.

  2014cited by this paper
• Fragile X Syndrome

  2014cited by this paper
• Mitochondrial complex I inhibition as a possible mechanism of chlorpyrifos induced neurotoxicity

  2014cited by this paper
• Molecular Advances Leading to Treatment Implications for Fragile X Premutation Carriers

  2014cited by this paper
• Genomic studies in fragile X premutation carriers

  2014cited by this paper
• Developmental neurotoxicity and anticonvulsant drugs: a possible link.

  2014cited by this paper
• Nanomolar Bifenthrin Alters Synchronous Ca2+ Oscillations and Cortical Neuron Development Independent of Sodium Channel Activity

  2014cited by this paper
• Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome.

  2013influential reference
• Toxicology of organophosphate and carbamate compounds

  2013cited by this paper
• Pesticides, depression and suicide: a systematic review of the epidemiological evidence.

  2013cited by this paper
• Longitudinal assessment of chlorpyrifos exposure and effect biomarkers in adolescent Egyptian agricultural workers

  2013cited by this paper
• Recurrent tonic–clonic seizures and coma due to ingestion of Type I pyrethroids in a 19-month-old patient

  2013cited by this paper
• Effect of chlorpyrifos on the inhibition of the enzyme acetylcholinesterase by cross-linking in water-supply samples and milk from dairy cattle.

  2013cited by this paper
• Prevalence of CGG expansions of the FMR1 gene in a US population‐based sample

  2012cited by this paper
• Clustered burst firing in FMR1 premutation hippocampal neurons: amelioration with allopregnanolone.

  2012cited by this paper
• Increased prevalence of seizures in boys who were probands with the FMR1 premutation and co-morbid autism spectrum disorder

  2012cited by this paper
• Defining genetically meaningful language and personality traits in relatives of individuals with fragile X syndrome and relatives of individuals with autism

  2012cited by this paper
• Neonatal exposure to phenobarbital potentiates schizophrenia-like behavioral outcomes in the rat.

  2012cited by this paper
• Toxicology of avermectins and milbemycins (macrocylic lactones) and the role of P-glycoprotein in dogs and cats.

  2012cited by this paper
• Early mitochondrial abnormalities in hippocampal neurons cultured from Fmr1 pre‐mutation mouse model

  2012cited by this paper
• Chlorpyrifos-oxon disrupts zebrafish axonal growth and motor behavior.

  2011cited by this paper
• Correlating neurobehavioral performance with biomarkers of organophosphorous pesticide exposure.

  2011cited by this paper
• Early postnatal exposure of rats to lamotrigine, but not phenytoin, reduces seizure threshold in adulthood

  2011cited by this paper
• FMR1 and the continuum of primary ovarian insufficiency.

  2011cited by this paper
• Effects of Neonatal Antiepileptic Drug Exposure on Cognitive, Emotional, and Motor Function in Adult Rats

  2011cited by this paper
• Effects of Chlorpyrifos and Chlorpyrifos-Oxon on the Dynamics and Movement of Mitochondria in Rat Cortical Neurons

  2011cited by this paper
• A novel FMR1 PCR method for the routine detection of low abundance expanded alleles and full mutations in fragile X syndrome.

  2010cited by this paper
• Minding the calcium store: Ryanodine receptor activation as a convergent mechanism of PCB toxicity.

  2010cited by this paper
• Therapeutic strategies to avoid long‐term adverse outcomes of neonatal antiepileptic drug exposure

  2010cited by this paper
• Early onset of neurological symptoms in fragile X premutation carriers exposed to neurotoxins.

  2010cited by this paper
• Advances in understanding the molecular basis of FXTAS.

  2010influential reference
• Antiepileptic Drug-Induced Cognitive Adverse Effects

  2009influential reference
• A Rapid Polymerase Chain Reaction-Based Screening Method for Identification of All Expanded Alleles of the Fragile X (FMR1) Gene in Newborn and High-Risk Populations

  2009cited by this paper
• Toxicology in the Fast Lane: Application of High-Throughput Bioassays to Detect Modulation of Key Enzymes and Receptors

  2009cited by this paper
• Chlorpyrifos and chlorpyrifos-oxon inhibit axonal growth by interfering with the morphogenic activity of acetylcholinesterase.

  2008cited by this paper
• Co‐occurring conditions associated with FMR1 gene variations: Findings from a national parent survey

  2008cited by this paper
• Cognitive Effects of Antiepileptic Drugs

  2008cited by this paper
• A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations.

  2008cited by this paper
• The fragile X prevalence paradox

  2008influential reference
• Neurobehavioral toxicology of pyrethroid insecticides in adult animals: a critical review.

  2008cited by this paper
• Fragile X‐associated tremor/ataxia syndrome: Clinical features, genetics, and testing guidelines

  2007cited by this paper
• Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS).

  2006cited by this paper
• Autism Spectrum Disorders and Attention-Deficit/Hyperactivity Disorder in Boys with the Fragile X Premutation

  2006cited by this paper
• Chlorpyrifos exerts opposing effects on axonal and dendritic growth in primary neuronal cultures.

  2005cited by this paper
• Fragile X-associated tremor/ataxia syndrome presenting in a woman after chemotherapy

  2005influential reference
• Phenotypic variation and FMRP levels in fragile X.

  2004cited by this paper
• Chlorpyrifos induces apoptosis in rat cortical neurons that is regulated by a balance between p38 and ERK/JNK MAP kinases.

  2004cited by this paper
• [Cognitive effects of antiepileptic drugs].

  2003cited by this paper
• Antiepileptic drugs and apoptotic neurodegeneration in the developing brain

  2002cited by this paper
• FMR1 and the fragile X syndrome: Human genome epidemiology review

  2001cited by this paper
• Transcription of the FMR1 gene in individuals with fragile X syndrome.

  2000cited by this paper
• FMRP expression as a potential prognostic indicator in fragile X syndrome.

  1999cited by this paper
• Organophosphorus pesticides: do they all have the same mechanism of toxicity?

  1999cited by this paper

• Toward an understanding of the role of the exposome on fragile X phenotypes.

  2023cites this paper
• Insight and Recommendations for Fragile X-Premutation-Associated Conditions from the Fifth International Conference on FMR1 Premutation

  2023cites this paper
• Influence of Gestational Chlorpyrifos Exposure on ASD-like Behaviors in an fmr1-KO Rat Model

  2022cites this paper
• Sulforaphane improves mitochondrial metabolism in fibroblasts from patients with fragile X-associated tremor and ataxia syndrome.

  2021cites this paper
• Evaluation of FMR1 gene mutations in Turkish women newly diagnosed with primary ovarian failure

  2019cites this paper
• General Anesthetic Use in Fragile X Spectrum Disorders

  2019cites this paper
• Screening for FMR1 expanded alleles in patients with Autism Spectrum Disorders in Manaus, Northern Brazil.

  2019cites this paper
• Learning problems on brain disorders

  2019cites this paper
• Fragile X-Associated Neuropsychiatric Disorders (FXAND)

  2018cites this paper
• Fragile X Syndrome in a Colombian Family

  2018cites this paper
• Genetic cluster of fragile X syndrome in a Colombian district

  2018cites this paper
• Fentanyl overdose in a female with the FMR1 premutation and FXTAS.

  2018cites this paper
• Increased severity of fragile X spectrum disorders in the agricultural community of Ricaurte, Colombia

  2018cites this paper
• Síndrome de Tremor Ataxia y Falla Ovárica Prematura en portadora de la premutación del gen FMR1

  2017cites this paper
• Tremor-Ataxia syndrome and primary ovarian insufficiency in anFMR1 premutation carrier

  2017cites this paper
• Psychopathology Increases With Age in Fragile X Carrier Mothers.

  2016cites this paper
• Associated Clinical Disorders Diagnosed by Medical Specialists in 188 FMR1 Premutation Carriers Found in the Last 25 Years in the Spanish Basque Country: A Retrospective Study

  2016cites this paper
• Alcohol use dependence in fragile X syndrome.

  2016cites this paper
• Aging in Fragile X Premutation Carriers

  2016cites this paper
• Fragile X-associated Tremor/Ataxia Syndrome: RNA or RAN?

  2016influential citation
• Fragile X-associated tremor/ataxia syndrome — features, mechanisms and management

  2016cites this paper